• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Vaccination Coverage by Age 24 Months Among Children Born During 2018-2019 - National Immunization Survey-Child, United States, 2019-2021
This report describes vaccination coverage by age 24 months using data from the National Immunization Survey-Child (NIS-Child).† Compared with coverage among children born during 2016-2017, coverage among children born during 2018-2019 increased for a majority of recommended vaccines. Coverage was >90% for ≥3 doses of poliovirus vaccine (93.4%), ≥3 doses of hepatitis B vaccine (HepB) (92.7%), ≥1 dose of measles, mumps, and rubella vaccine (MMR) (91.6%), and ≥1 dose of varicella vaccine (VAR) (91.1%); coverage was lowest for ≥2 doses of hepatitis A vaccine (HepA) (47.3%). Vaccination coverage overall was simi...
Source: MMWR Morb Mortal Wkl... - January 12, 2023 Category: Epidemiology Authors: Holly A Hill Michael Chen Laurie D Elam-Evans David Yankey James A Singleton Source Type: research

Vaccination Coverage by Age 24 Months Among Children Born in 2017 and 2018 - National Immunization Survey-Child, United States, 2018-2020
MMWR Morb Mortal Wkly Rep. 2021 Oct 15;70(41):1435-1440. doi: 10.15585/mmwr.mm7041a1.ABSTRACTImmunization is a safe and cost-effective means of preventing illness in young children and interrupting disease transmission within the community.* The Advisory Committee on Immunization Practices (ACIP) recommends vaccination of children against 14 diseases during the first 24 months of life (1). CDC uses National Immunization Survey-Child (NIS-Child) data to monitor routine coverage with ACIP-recommended vaccines in the United States at the national, regional, state, territorial, and selected local levels.† CDC assessed vaccin...
Source: MMWR Morb Mortal Wkl... - October 14, 2021 Category: Epidemiology Authors: Holly A Hill David Yankey Laurie D Elam-Evans James A Singleton Natalie Sterrett Source Type: research

Human papillomavirus (HPV) vaccine uptake among a community-recruited sample of gay, bisexual, and other men who have sex with men in the three largest cities in Canada from 2017 to 2019
CONCLUSIONS: Sixty-five to 74% of men eligible for publicly-funded vaccine across the three cities remained unvaccinated against HPV by 2019. High vaccine cost may partly explain even lower uptake among men ≥ 27 years old. Men seeking sexual health care were more likely to initiate vaccination; bundling vaccination with these services may help improve HPV vaccine uptake.PMID:34074547 | DOI:10.1016/j.vaccine.2021.05.031
Source: Vaccine - June 2, 2021 Category: Allergy & Immunology Authors: R Grewal S L Deeks T A Hart J Cox A De Pokomandy T Grennan G Lambert D Moore M Brisson F Coutl ée M Gaspar C George D Grace J Jollimore N J Lachowsky R Nisenbaum G Ogilvie C Sauvageau D H S Tan A Yeung A N Burchell Source Type: research